Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Yesterday 10:58 PM
NEV Maker Leapmotor Exposed to Rights Protection at Chongqing Auto Show
Leapmotor encountered rights protection at the 2022 Chongqing Auto Show on June 25. It was accused of presenting a black screen on the new car, promising to return the car while regretting the company’s response.
Yesterday 03:41 PM